Profile data is unavailable for this security.
About the company
CanBas Co Ltd is a Japan-based company mainly engaged in drug development and research. The company is mainly engaged in the basic anticancer drug discovery research (including development of drug discovery concepts, selection of drug candidate compounds using methods based on these concept developments, simple animal studies, and collection and analysis of basic data on anticancer drug candidates that have entered development) and early clinical development (including preclinical studies prior to submission of applications to start clinical trials and the first part of clinical trials).
- Revenue in JPY (TTM)0.00
- Net income in JPY-1.09bn
- Incorporated2000
- Employees12.00
- LocationCanBas Co Ltd2-2-1, Ote-machiNUMAZU-SHI 410-0801JapanJPN
- Phone+81 559543666
- Fax+81 559543668
- Websitehttps://www.canbas.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Delta-Fly Pharma Inc | 0.00 | -1.43bn | 5.02bn | 13.00 | -- | 4.07 | -- | -- | -197.24 | -197.24 | 0.00 | 149.78 | 0.00 | -- | -- | 0.00 | -120.07 | -67.70 | -141.25 | -72.02 | -- | -- | -- | -877.69 | -- | -243.15 | 0.00 | -- | -- | -- | -7.57 | -- | -9.04 | -- |
| Solasia Pharma KK | 408.00m | -1.18bn | 6.00bn | 24.00 | -- | 3.00 | -- | 14.70 | -6.96 | -6.96 | 2.40 | 10.01 | 0.1432 | 2.01 | 3.06 | 17,000,000.00 | -41.50 | -48.57 | -53.67 | -58.83 | 51.23 | 71.01 | -289.71 | -300.89 | 1.68 | -400.00 | 0.2327 | -- | -43.50 | 14.18 | 56.36 | -- | -- | -- |
| COSMO BIO COMPANY, LIMITED | 9.46bn | 408.00m | 6.31bn | 155.00 | 14.91 | 0.6836 | 11.11 | 0.6672 | 69.94 | 69.94 | 1,620.67 | 1,525.81 | 0.8484 | 6.09 | 2.87 | 61,000,000.00 | 3.80 | 5.62 | 4.54 | 6.72 | 33.82 | 37.40 | 4.48 | 6.23 | 5.15 | -- | 0.0021 | 33.53 | -2.23 | 5.16 | -14.51 | 11.20 | -8.03 | 16.47 |
| MEDRx Co Ltd | 22.57m | -770.66m | 6.79bn | 22.00 | -- | 3.18 | -- | 300.65 | -20.97 | -20.97 | 0.6128 | 47.84 | 0.0143 | 0.00 | 4.22 | 1,025,955.00 | -48.80 | -58.15 | -50.27 | -62.23 | 100.00 | 95.70 | -3,414.38 | -1,526.17 | 43.57 | -- | 0.00 | -- | -50.35 | 28.60 | 16.04 | -- | -55.29 | -- |
| NIPPON CHEMIPHAR CO., LTD. | 30.75bn | -180.00m | 6.85bn | 887.00 | -- | 0.3141 | 5.36 | 0.2227 | -49.89 | -49.89 | 8,520.20 | 5,115.78 | 0.6268 | 2.14 | 2.70 | 34,665,160.00 | -0.3689 | 0.7482 | -0.5204 | 1.08 | 25.17 | 30.99 | -0.5887 | 1.13 | 1.53 | -- | 0.4791 | 50.73 | -2.57 | -2.10 | -153.10 | -- | 24.62 | -12.94 |
| Perseus Proteomics Inc | 100.40m | -1.10bn | 7.13bn | 25.00 | -- | 4.13 | -- | 71.01 | -93.74 | -93.74 | 8.52 | 117.15 | 0.0471 | 3.35 | 8.55 | 4,016,080.00 | -51.85 | -41.34 | -54.94 | -43.43 | 87.33 | 91.72 | -1,100.04 | -891.26 | 12.77 | -- | 0.00 | -- | 6.58 | -18.31 | -40.34 | -- | 60.30 | -- |
| Symbio Pharmaceuticals Ltd | 4.64bn | -2.74bn | 7.99bn | 109.00 | -- | 1.11 | -- | 1.72 | -66.88 | -66.88 | 113.80 | 156.38 | 0.5439 | 2.76 | 5.14 | 42,594,130.00 | -32.15 | -19.18 | -35.33 | -23.62 | 78.38 | 65.84 | -59.12 | -24.32 | 10.43 | -- | 0.00 | -- | -44.15 | 7.82 | -266.45 | -- | 42.39 | -- |
| K Pharma Inc | 500.00m | -221.98m | 8.47bn | 15.00 | -- | 2.95 | -- | 16.94 | -18.94 | -18.94 | 43.04 | 247.43 | 0.2095 | 4.49 | -- | 33,333,330.00 | -9.30 | -- | -9.83 | -- | 91.00 | -- | -44.40 | -- | 42.60 | -- | 0.00 | -- | -- | -- | 166.34 | -- | -- | -- |
| Wakamoto Pharmaceutical Co Ltd | 7.74bn | 108.96m | 8.85bn | 274.00 | 80.91 | 0.733 | 17.00 | 1.14 | 3.14 | 3.14 | 222.97 | 346.51 | 0.4971 | 2.09 | 2.57 | 28,242,430.00 | 0.70 | -2.28 | 0.8046 | -2.64 | 46.52 | 51.00 | 1.41 | -3.97 | 3.85 | -- | 0.0083 | -- | -10.65 | -6.35 | -21.19 | -- | 4.93 | -- |
| CanBas Co Ltd (Parent) | 0.00 | -1.09bn | 9.61bn | 12.00 | -- | 3.21 | -- | -- | -64.47 | -64.47 | 0.00 | 166.10 | 0.00 | -- | -- | 0.00 | -43.91 | -65.86 | -45.99 | -79.11 | -- | -- | -- | -1,094.10 | -- | -- | 0.00 | -- | -- | -- | -45.41 | -- | -- | -- |
| Kohjin Bio Co Ltd | 4.77bn | 384.98m | 9.61bn | 159.00 | 20.37 | 2.34 | 14.04 | 2.01 | 92.30 | 92.30 | 1,122.07 | 802.50 | -- | -- | -- | 30,000,600.00 | -- | -- | -- | -- | 39.44 | -- | 8.07 | -- | 1.14 | -- | 0.4249 | -- | 0.5715 | -- | -53.61 | -- | -- | -- |
| Oncolys Biopharma Inc | 28.04m | -1.98bn | 11.47bn | 34.00 | -- | 6.50 | -- | 408.94 | -107.77 | -107.77 | 1.52 | 84.14 | 0.0127 | 0.00 | 0.1476 | 824,647.10 | -89.46 | -45.75 | -101.52 | -51.86 | 100.00 | 60.46 | -7,058.44 | -233.66 | 8.82 | -- | 0.1416 | -- | -93.54 | -17.86 | -68.72 | -- | 28.18 | -- |
| Stella Pharma Corp | 269.49m | -763.75m | 12.24bn | 44.00 | -- | 4.91 | -- | 45.44 | -24.63 | -24.63 | 8.70 | 76.12 | 0.0661 | 0.0508 | 3.98 | 6,124,796.00 | -18.74 | -22.50 | -21.00 | -24.83 | 80.63 | -- | -283.40 | -488.65 | 5.52 | -1,319.97 | 0.2819 | -- | 17.65 | -- | 1.94 | -- | -5.87 | -- |
| ReproCell Inc | 2.43bn | -31.42m | 12.32bn | 96.00 | -- | 1.47 | 2,162.24 | 5.08 | -0.3466 | -0.3466 | 28.34 | 93.45 | 0.2788 | 5.41 | 5.60 | 25,279,340.00 | -0.3609 | -7.35 | -0.3932 | -8.00 | 46.19 | 39.83 | -1.29 | -27.16 | 10.54 | -- | 0.00 | -- | -17.83 | 17.39 | 89.71 | -- | 13.27 | -- |
| RaQualia Pharma Inc | 2.18bn | -253.40m | 12.72bn | 67.00 | -- | 2.12 | -- | 5.84 | -11.72 | -11.72 | 100.79 | 277.21 | 0.247 | 2.76 | 3.03 | 32,526,720.00 | -2.87 | 2.13 | -3.18 | 2.26 | 88.70 | 88.49 | -11.63 | 5.32 | 3.53 | -- | 0.4031 | 0.00 | -34.85 | 20.62 | -144.74 | -- | 0.0967 | -- |
| Ohki Healthcare Holdings Co Ltd | 334.66bn | 2.21bn | 13.89bn | 632.00 | 6.15 | 0.4837 | 5.55 | 0.0415 | 160.45 | 160.45 | 24,293.96 | 2,040.70 | 2.56 | 13.33 | 4.80 | 529,526,900.00 | 1.63 | 1.85 | 7.07 | 8.42 | 5.14 | 6.16 | 0.6356 | 0.7178 | 0.8922 | -- | 0.1996 | 13.92 | 9.92 | 5.30 | 1.28 | 1.51 | -5.34 | 5.92 |
Data as of Jul 05 2024. Currency figures normalised to CanBas Co Ltd's reporting currency: Japanese Yen JPY
0.58%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Simplex Asset Management Co., Ltd.as of 06 Jun 2024 | 94.40k | 0.52% |
| Daiwa Asset Management Co. Ltd.as of 29 Aug 2022 | 10.00k | 0.06% |
Data from 31 Mar 2024 - 25 Jun 2024Source: FactSet Research Systems Inc.
